宝石能谱ct在鉴别肝脏血管瘤与转移瘤中的应用价值

《宝石能谱ct在鉴别肝脏血管瘤与转移瘤中的应用价值》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、授予单位代码10089学号或申请号20122531对#(E搿大空HebeiMedicalUniversity硕士学位论文科学学位宝石能谱CT在鉴别肝脏血管瘤与转移瘤中的应用价值研究生：李晓光导师：孙吉林教授专业：影像医学与核医学二级学院：河北省人民医院2015年3月河北医科大学学位论文使用授权及知识产权归属承诺本学位论文在导师（或指导小组）的指导下，由本人独立完成。本学位论文研究所获得的研究成果，其知识产权归河北医科大学所有。河北医科大学有权对本学位论文进行交流、公开和使用。凡发表与学位论文主要内容相关的论文，第一署名为单位河北医科大学，试验材料、原始数据、申报的专利

2、等知识产权均归河北医科大学所有。否则，承担相应法律责任。研究生签名幻导师签章：二级学院领导盖章：年；月介日河北医科大学研究生学位论文独创性声明本论文是在导师指导下进行的研究工作及取得的研究成果，除了文中特别加以标注和致谢等内容外，文中不包含其他人已经发表或撰写的研究成果，指导教师对此进行了审定。本论文由本人独立撰写，文责自负。研究生签名：导师签章：抓年2月邳日目录中文摘要·············································································1英文摘要··················

3、···························································3英文缩写·············································································4研究论文宝石能谱CT在鉴别肝脏血管瘤与转移瘤中的应用价值前言·············································································7材料与方法································

4、····································7结果·············································································9附图·············································································11附表·············································································21讨论······

5、·······································································24结论·············································································30参考文献·······································································31综述宝石能谱CT的研究进展···········································

6、·····34致谢···················································································41个人简历·············································································42中文摘要宝石能谱CT在鉴别肝脏血管瘤与转移瘤中的应用价值摘要目的：肝脏是人体最重要的代谢解毒器官和最大的消化器官，具有重要的生理功能。肝脏有肝动脉与门静脉的双重供血，其3/4的血供来源于门静脉，1/4的血供来源于肝动脉。

7、由于其特殊的解剖结构与丰富的血供，使其成为原发性肿瘤和继发性肿瘤的好发器官。其中，肝脏血管瘤与转移瘤在临床上较为常见。由于二者的治疗及预后不同，所以两者鉴别诊断的准确性对临床具有重要的指导意义。本研究通过对肝脏血管瘤与转移瘤的CT图像进行能谱分析，初步探讨宝石能谱CT在肝脏血管瘤与转移瘤鉴别诊断中的价值，为临床治疗以及预后提供更有力的依据。方法：回顾性分析2013年5月至2014年12月在我院就诊的30例肝脏病变患者。其中肝脏血管瘤患者15例（男性7例，女性8例，年龄30～88岁，平均年龄55.2岁）；肝脏转移瘤患者15例（男性9例，女性6例，年龄5